Clarification of the pathogenesis and treatment of autism spectrum disorders is one of the challenges today. In this study, we examine scalp hair concentrations of 26 trace elements for 1,967 children with autistic disorders (1,553 males and 414 females). Five-hundred and eighty-four (29.7%), 347 (17.6%) and 114 (5.8%) subjects was found deficient in zinc, magnesium and calcium, respectively and 2.0% or less in the other essential metals. The incidence rate of mineral deficiency was highly observed in infants aged 0-3 year-old. In contrast, 339 (17.2%), 168 (8.5%) and 94 (4.8%) individuals was found suffering from high burden of aluminium, cadmium and lead and 2.8% or less from mercury and arsenic burden. These findings suggest that infantile zinc- and magnesium-deficiency and/or toxic metal burdens may epigenetically play principal roles as environmental factors in autistic disorders and that metallomics approach may lead to early screening and prevention of the neurodevelopment disorders.
Autism spectrum disorders are a group of neural development disorders characterized by impairments in social interaction and communication and by the presence of restricted and repetitive behaviours1,2 and the prevalence of this disease continues to increase up to 1 in 88 children1,2,3,4. Autism spectrum disorders are known to be highly heritable (~90%) and some related genes have been reported5,6. However, the critical genetic determinants are still unclarified2,4 and the interaction of heritable factors with uncertified lifestyle and environmental factors seem play a significant role in the aetiology. For example, organic mercury had been claimed one of environmental candidates causing autistic disorders7, but its relationship remains to be established. Recently, epigenetic alteration of gene expression by environmental factors is considered one of key events in the pathogenesis of genetic diseases8 and some toxic elements such as cadmium and arsenic have been reported to be candidate factors that induce epigenetic disorders9,10,11,12,13.
Recent great advances in high-sensitive and reliable trace element analysis method using inductively coupled plasma mass spectrometry (ICP-MS) have enabled us to apply it to forensic medical researches and estimating chronic toxic metal burden and mineral deficiency in human body14,15. Thus, clinical applications of the reliable hair mineral analysis method with ICP-MS have been tried for investigating the association of some diseases and symptoms with trace element kinetics including toxic metals and essential minerals16,17,18,19,20,21.
For the last six years, we have examined the association of toxic metal burdens with autistic disorders and reported that some of the autistic children have suffered from high accumulation of toxic metals such as cadmium, lead or aluminium22,23,24. Recently, we demonstrated the association of infantile zinc deficiency with autism spectrum disorders25.
In this metallomics analysis study, we have determined human scalp hair concentrations of 26 trace elements for 1,967 children with autistic disorders aged 0–15 years and showed that many of the patients, especially in infants aged 0–3 year-old, are suffering from marginal to severe zinc- and magnesium-deficiency and/or high burdens of several toxic metals such as aluminium, cadmium and lead. These findings suggest that there is a critical term “infantile window” in neurodevelopment and probable for therapy of autistic disorders.
The histogram of hair logarithmic zinc concentrations for 1,967 children with autistic spectrum disorders is shown in Figure 1. The distribution of the zinc concentration was non-symmetric with tailing in lower range and 584 in 1,967 subjects (29.7%) were found to have lower zinc concentration than –2 S.D. (standard deviation) level of the reference range (86.3–193 ppm; geometric mean = 129 ppm), estimated as zinc deficiency. The incidence rate of zinc deficiency in the age groups of 0–3, 4–9 and 10–15 year-old was estimated 43.5, 28.1 and 3.3% in male and 52.5, 28.7 and 3.5% in female, respectively (Table 1) and a significant correlation of zinc concentration with age (r = 0.367, p < 0.0001) was observed (Fig. 2), indicating that infants are more liable to zinc deficiency than elder children. The minimum zinc concentration of 10.7 ppm detected in a 2-year-old boy corresponded to about 1/12 of the mean reference level. The zinc concentration of only one 0-year old female subject was 173 ppm in the normal range (Fig. 2) and seem be a suspect, because she was suffered from high burdens of aluminium (52.5 ppm), lead (9.1 ppm), iron (12.8 ppm) and copper (134 ppm). There was no significant gender difference in hair zinc concentration and incidence rate of zinc deficiency.
Following to zinc deficiency, magnesium and calcium deficiency was observed in 347 (17.6%) and 114 (5.8%) individuals in the autistic children (Table 2) and for the other essential metals such as iron, chromium, manganese, copper and cobalt, their incidence rates of deficiency were 2.0% or less. The incidence rate of magnesium deficiency in the age groups of 0–3, 4–9 and 10–15 year-old was 27.0, 17.1 and 4.2% in male and 22.9, 12.7 and 4.3% in female subjects, respectively (Table 3) and a significant correlation of magnesium concentration with age (r = 0.362, p < 0.0001) was observed (Fig. 3), suggesting that infants are also liable to magnesium deficiency than elder children. The minimal magnesium concentration of 3.88 ppm detected in a 2-year-old girl corresponded to almost 1/10 of the mean reference level (39.5 ppm). Calcium deficiency was observed only in lower age groups less than 10 year-old (Table 4).
In contrast, high toxic metal burden of aluminium, cadmium and lead of over their +2 S.D. level was observed in 339 (17.2%), 168 (8.5%) and 94 (4.8%) individuals and their incidence rates were higher than that of mercury and arsenic (2.8 and 2.6%, respectively) (Table 5). The detected maximal concentration of aluminium, cadmium and lead was 79.4 ppm in a 4-year-old boy, 5.47 ppm in a 5-year-old boy and 24.9 ppm in a 5-year-old girl, respectively, corresponding to 21-, 782- and 57-fold of each mean reference level. The maximal burden level of mercury and arsenic was 36.3 ppm and 1.7 ppm, respectively, corresponding to about 9- and 33-fold of the mean reference level.
Figure 4 shows a typical autistic metallome profile in a 1-year-old boy suffering from severe zinc- and magnesium-deficiency and simultaneous high burdens of cadmium and lead. Another autistic metallome profile with high burdens of aluminium and manganese in a 2-year-old boy is shown in Fig. 5.
Zinc is an essential trace element that plays important roles in nucleic acid/protein synthesis, cell replication, tissue growth and repair, especially in pregnant women and infants. Therefore, zinc deficiency is known associated with various pathological conditions, including dysgeusia, delayed wound healing, impaired immunity, retarded growth and neural-degenerative diseases26,27,28,29,30.
Recently we reported that many infants with autistic disorders are suffered from marginal to severe zinc deficiency, suggesting considerable relationship of infantile zinc deficiency with autism25. In the present study, we have determined scalp hair concentrations of 26 trace elements for 1,967 subjects diagnosed with autism spectrum disorders and investigated their association with mineral disorders.
The histogram of logarithmic zinc concentration in the autistic children showed a non-symmetric profile with a marked tailing in lower range, indicating that about 30% of the autistic children were estimated as zinc deficiency (Fig. 1). In particular, nearly one half (male: 43.5%; female: 52.5%) of the infant group aged 0–3 year-old were found to suffer from marginal to severe zinc deficiency (Table 1). Thus, the lowest mean zinc concentration was observed in the infant group aged 0–3 year-old in both genders (male: 87 ppm; female: 81 ppm) and a high significant correlation of the zinc concentration with age was observed in the autistic children (Fig. 2). These findings suggest that infants are liable to zinc deficiency because they need larger amount of zinc (per kg body weight) for their development and growth. In addition, age-related changes in the production of metallothionein proteins and differences in glutathione levels may be associated with the age-related differences in zinc requirements31. There was little gender difference in zinc deficiency rate and also in hair zinc concentration (Table 1).
Next to zinc deficiency, a considerable number of autistic children were found to be deficient in magnesium and calcium and no significant deficiency was observed for the other essential metals (Table 2). The incidence rate of magnesium deficiency in the age group of 0–3 and 4–9 year-old was 27.0 and 17.1% in male and 22.9 and 12.7% in female subjects, respectively, suggesting that about one fourth of the infant group are suffered from a simultaneous deficiency of zinc and magnesium. Compared to magnesium, significant deficiency in calcium was observed only in the lower age groups (Table 4). These findings indicate that infantile autistic children have a character liable to deficiency in zinc and magnesium.
There are numerous studies with the same theme reporting nutritional status and mineral deficiencies in autistic children32,33,34,35,36. However, the conclusions of their studies, in which the restricted subject age range (over 3 or 5 year-old) and number of minerals were examined, were not consistent and the critical environmental factors remained to be established. In this metallomics analysis study for the 1,967 autistic children aged 0–15 year-old, we were able to demonstrate not only the critical epigenetic factor (zinc- and magnesium-deficiency and/or high burdens of aluminium, cadmium and lead) but also the presence of another critical factor, “infantile window” in neurodevelopment and for therapy probably.
Arnold et al.37 reported that mean serum zinc levels were significantly lower in both autism and ADHD groups and that serum zinc level correlated inversely with parent- and teacher-rated inattention in ADHD children. Furthermore, it is reported that zinc treatment was significantly superior to placebo in reducing symptoms of hyperactivity, impulsivity and impaired socialization in ADHD patients38,39. Other preliminary human study showed that many children with ADHD have lower zinc concentration in comparison to healthy children and that zinc supplement as an adjunct to methylphenidate has favourable effects in the treatment of ADHD children, pointing to the possible association of zinc deficiency and ADHD pathophysiology40.
Kozielec et al.41 have reported that in hyperactive 116 children with ADHD, magnesium deficiency was found in the 95% of the subjects, most frequently in hair (77.6%), next in red-blood cells (58.6%) and in blood serum (33.6%). Furthermore, they reported that a significant decrease of hyperactivity and increase in hair magnesium contents has been achieved in the group of ADHD children given six months of magnesium supplementation42. Mousain-Bosc et al.43 also reported that 52 hyper-excitable children have low intra-erythrocyte magnesium levels with normal serum magnesium values and that magnesium/vitamin B6 supplementation can restore the erythrocyte magnesium levels to normal and improve their abnormal behaviours. They also reported that thirty three children with clinical symptoms of pervasive developmental disorder or autism (PDD) exhibit significantly lower red blood cell magnesium values and that the combination therapy with magnesium/vitamin B6 for six months improved significantly PDD symptoms in 23/33 children (p < 0.0001) with concomitant increases in intra-erythrocyte magnesium values44.
These findings are consistent with a gradient overarching disorder hypothesis for autism spectrum disorders and ADHD45 and indicate that infantile mineral deficiency in zinc and magnesium plays epigenetically principal roles as environmental factors in the pathogenesis of these neurodevelopment disorders, suggesting that the supplementation of deficient minerals during the critical “infantile window” may be useful for treatment and prevention of these diseases.
Recently, dietary restriction-induced zinc deficiency has been reported to up-regulate intestinal zinc-importer (ZIP4) and induce the increase in ZIP4 protein located to the plasma membrane of enterocytes46,47. This adoptive response to zinc deficiency is known to lead to increase in the risk of high-uptake of toxic metals such as cadmium and lead48. Thus, infants with zinc deficiency are liable to increased risk of absorbing high amount of toxic metals and retaining them in their bodies, as shown in Table 5 and Fig. 4. These findings suggest that the increased toxic metal burdens attendant on zinc deficiency may also epigenetically contribute to the pathogenesis of these diseases.
Maternal cigarette smoking has been reported to be associated with lower zinc and higher cadmium and lead concentrations in their neonates49. During pregnancy and lactation, these toxic metals accumulated in the maternal bone tissues are co-transferred with calcium to foetal and new-born bodies through activated bone-resorption49,50,51,52.
Eklund and Oskarsson53 reported that soy-based formulas contain approximately six times more cadmium than cow's milk formulas and cereal-based formulas have 4–21 times higher levels. Thus, the dietary intake of the toxic metal in the children fed on infant formulas and weaning foods may be high in comparison with breast milk-fed infants.
For mercury and arsenic, the maximum burden level of 9.3- and 33.5-fold of the reference level (Table 5) may also epigenetically play some pathogenic roles in the respective autistic individuals, even though their incidence rate was 2.8% or less.
In summary, this metallomics study demonstrates that many of autistic infants have been suffered from marginal to severe zinc- and magnesium-deficiency and/or high toxic metal burdens of aluminium, cadmium, lead and so on. These findings suggest that infantile mineral deficiency and/or toxic metal burdens may epigenetically play principal roles in the pathogenesis of autism spectrum disorders and that there is a critical term “infantile window” in neurodevelopment and for its therapy. Therefore, it is possible that autistic infants may respond to nutritional approach supplementing deficient nutrients and detoxifying accumulated toxic metals on the basis of the evidence. This evidence-based nutritional approach may yield a new pathway into treatment and prevention of infantile patients with autistic disorders including the suspects. Well-controlled intervention studies for this novel nutritional therapy are desired to establish the epigenetic roles of infantile mineral deficiencies and/or toxic metal burdens in the pathogenesis of neurodevelopment disorders such as autism spectrum disorders and ADHD.
In conclusion, this preliminary study demonstrates that many of infantile patients diagnosed with autism have been suffered from marginal to severe zinc- and magnesium-deficiency and/or high toxic metal burdens of aluminium, cadmium, lead and so on, suggesting that these mineral disorders may epigenetically play principal roles as environmental factors in the pathogenesis of autism spectrum disorders.
Samples and trace element analysis
On the basis of informed consent, scalp hair samples from 1,967 (male: 1,553; female: 414) autistic Japanese subjects aged 0–15 years were collected in the period from June 2005 to September 2007, although 0 year-old subject was only one (11 month-old female). These subjects were comprised of the children diagnosed with autistic spectrum disorders by their physicians. Hair sampling was recommended to cut as close to the scalp of the occipital area as possible.
Hair sample of 75 mg was weighed into 50 ml plastic tube and washed with acetone and then with 0.01% Triton solution, as recommended by the Hair Analysis Standardization Board54. The washed hair sample was mixed with 10 ml 6.25% tetra methyl ammonium hydroxide (TMAH, Tama Chemical, Kawasaki, Japan) and 50 μl 0.1% gold solution (SPEX Certi Prep, Metuchen, NJ, USA) and then dissolved at 75 centigrade with shaking for 2 hours. After cooling the solution to room temperature, internal standard (scandium, gallium and indium) solution was added and after adjusting its volume gravimetric, the obtained solution was used for multi-mineral analysis. The trace element concentrations were determined with inductively coupled plasma mass spectrometry (ICP-MS; 7500 ce, Agilent Technologies, Santa Clara, CA, USA) as reported previously19,20 and expressed as ng g−1 hair (ppb) or μg g−1 hair (ppm). Human hair certified reference material (NIES CRM No. 13) was used to check for the accuracy of analysis. The inter-daily variation of zinc, magnesium, calcium, aluminium, cadmium, lead, mercury and arsenic determination was 2.2, 9.6, 6.3, 8.2, 6.9, 11.1, 9.4 and 6.9%. The control geometric mean value and reference range for each trace element was obtained from the data for 436 male healthy subjects aged 21–40 year-old, as previously reported19,20,25.
This study has been approved by review of the ethical committee of La Belle Vie Research Laboratory. All of the data obtained are held securely in such a form as to ensure anonymity.
Because each trace element concentration in scalp hair was almost log-normally distributed, the mineral concentration was converted to logarithm and the geometric rather than arithmetic mean is used as representative of its hair concentration. The relation between age and zinc/magnesium concentration of the subjects was examined by Pearson's correlation coefficient test.
Weintraub, K. Autism counts. Nature 479, 22–24 (2011).
Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466, 368–372 (2010).
Chakrabarti, S. & Fombonne, E. Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am. J. Psychiatry 162, 1133–1141 (2005).
Hughes, V. Autism: Complex disorder. Nature 491, S2–S3 (2012).
Bailey, A. et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63–77 (1995).
Marshall, C. R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488 (2008).
Dufault, R. et al. Mercury exposure, nutritional deficiencies and metabolic disruption may affect learning in children. Behav. Brain Funct. 5, 44–58 (2009).
O'Rahilly, S. Human genetics illuminates the paths to metabolic disease. Nature 462, 307–314 (2009).
Jin, Y. H. et al. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 34, 239–241 (2003).
Takiguchi, M., Achanzar, W. E., Qu, W., Li, G. & Waalkes, M. P. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 286, 355–365 (2003).
Arita, A. & Costa, M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 1, 222–228 (2009).
Perera, F. & Herbstman, J. Prenatal environmental exposure, epigenetics and disease. Reprod. Toxicol. 31, 363–373 (2011).
Jakovcevski, M. & Akbarian, S. Epigenetic mechanisms in neurological disease. Nat. Med. 18, 1194–1204 (2012).
Rodushkin, I. & Axelsson, M. D. Application of double focusing sector field ICP-MS for multi elemental characterization of human hair and nails. Part I. Analytical methodology. Sci. Total Environ. 250, 83–100 (2000).
Goulle, J. P. et al. Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair: Reference values. Forens. Sci. Intern. 153, 39–44 (2005).
Wang, C. T., Chang, W. T., Zeng, W. F. & Lin, C. H. Concentrations of calcium, copper, iron, magnesium, potassium, sodium and zinc in adult female hair with different body mass indexes in Taiwan. Clin. Chem. Lab. Med. 43, 389–393 (2005).
Munakata, M. et al. A preliminary analysis of trace elements in the scalp hair of patients with severe motor disabilities receiving enteral nutrition. Brain Development 28, 521–525 (2006).
Yasuda, H., Yonashiro, T., Yoshida, K., Ishii, T. & Tsutsui, T. Mineral imbalance in children with autistic disorders. Biomed. Res. Trace Elem. 16, 285–291 (2005).
Yasuda, H., Yonashiro, T., Yoshida, K., Ishii, T. & Tsutsui, T. Relationship between body mass index and minerals in male Japanese adults. Biomed. Res. Trace Elem. 17, 316–321 (2006).
Yasuda, H. et al. Metallomics study using hair mineral analysis and multiple logistic regression analysis: relationship between cancer and minerals. Environ. Health Prev. Med. 14, 261–266 (2009).
Ochi, A. et al. Elemental concentrations in scalp hair, nutritional status and health-related quality of life in haemodialysis patients. Therap. Apheresis Dialysis 16, 127–133 (2012).
Yasuda, H., Yonashiro, T., Yoshida, K., Ishii, T. & Tsutsui, T. High toxic metal levels in scalp hair of infants and children. Biomed. Res. Trace Elem. 16, 39–45 (2005).
Yasuda, H., Yoshida, K., Segawa, M., Tokuda, R., Yasuda, Y. & Tsutsui, T. High accumulation of aluminium in hairs of infants and children. Biomed. Res. Trace Elem. 19, 57–62 (2008).
Yasuda, H., Yoshida, K., Yasuda, Y. & Tsutsui, T. Two age-related accumulation profiles of toxic metals. Cur. Aging Sci. 5, 105–111 (2012).
Yasuda, H., Yoshida, K., Yasuda, Y. & Tsutsui, T. Infantile zinc deficiency: Association with autism spectrum disorders. Sci. Rep. 1, 129; 10.1038/srep00129 (2011).
Prasad, A. S. Impact of the discovery of human zinc deficiency on health. J. Am. Coll. Nutr. 28, 257–265 (2009).
Arnold, L. E. & DiSilvestro, R. A. Zinc in attention-deficit/hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 15, 619–627 (2005).
DiGirolamo, A. M. & Raminez-Zea, M. Role of zinc in maternal and child mental health. Am. J. Clin. Nutr. 89 (suppl), 940S–945S (2009).
Scheplyagina, L. A. Impact of the mother's zinc deficiency on the woman's and new-borns health status. J. Trace Elem. Med. Biol. 19, 29–35 (2005).
Plum, L. M., Rink, L. & Haase, H. The essential toxin: Impact of zinc on human health. Intern. J. Environ. Res. Public Health, 7, 1342–1365 (2010).
Dufault, R., Lukiw, W. J., Crider, R., Schnoll, R., Wallinga, D. & Deth, R. A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States. Clin. Epigenetics 4, 6 (2012).
Yorbik, O., Akay, C., Sayal, A., Cansever, A., Sohmen, T. & Cavdar, A. O. Zinc status in autistic children. J. Trace Elem. Exp. Med. 17, 101–107 (2004).
Fido, A. & Al-Saad, S. Toxic trace elements in the hair of children with autism. Autism 9, 290–298 (2005).
Adams, J. B., Holloway, C. E., George, F. & Quig, D. Analyses of toxic metals and essential minerals in the hair of Arizona children with autism and associated conditions and their mothers. Biol. Trace Elem. Res. 110, 193–209 (2006).
Faber, S., Zinn, G. M., Kern, J. C. & Kingston, H. M. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers 14, 171–180 (2009).
Lakshmi Priya, M. D. & Geetha, A. Level of trace elements (copper, zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol. Trace Elem. Res. 142, 148–158 (2011).
Arnold, L. E. et al. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J. Child Adoles. Psychopharmacol. 15, 628–636 (2005).
Yorbik, O., Ozdag, M. F., Olgun, A., Senol, M. G., Bek, S. & Akman, S. Potential effects of zinc on information processing in boys with attention deficit hyper-activity disorder. Progr. Neuropsychopharmacol. Biol. Psychiatry 32, 662–667 (2008).
DiGirolamo, A. M. et al. Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am. J. Clin. Nutr. 92, 1241–1250 (2010).
Akhondzadeh, S., Mohammadi, M. R. & Khademi, M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomised trial [ISRCTN64132371]. BMC Psychiatry, 4, 9–14 (2004).
Kozielec, T. & Starobrat-Hermelin, B. Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes. Res. 10, 143–148 (1997).
Starobrat-Hermelin, B. & Kozielec, T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes. Res. 10, 149–156 (1997).
Mousain-Bose, M., Roche, M., Rapin, J. & Bali, J. P. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J. Am. Coll. Nutr. 23, 545S–548S (2004).
Mousain-Bose, M., Roche, M., Polge, A., Pradal-Prat, D., Rapin, J. & Bali, J. P. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitanin B6 II. Pervasive developmental disorder-autism. Magnes. Res. 19, 53–62 (2006).
Van der Meer, J. M. et al. Are autism spectrum disorder and attention-deficit/hyperactivity disorder different manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and population-based sample. J. Am. Acad. Child Adolesc. Psychiatry 51, 1160–1172 (2012).
Dufner-Beattie, J., Kuo, Y. M., Gitschier, J. & Andrews, G. K. The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5. J. Biol. Chem. 279, 49082–49090 (2004).
Lichten, L. A. & Cousins, R. J. Mammalian zinc transporters: nutritional and physiologic regulation. Ann. Rev. Nutr. 29, 153–176 (2009).
Goyer, R. A. Toxic and essential metal interactions. Ann. Rev. Nutr. 17, 37–50 (1997).
Razagui, I. B. & Ghribi, I. Maternal and neonatal scalp hair concentrations of zinc, cadmium and lead: relationship to some lifestyle factors. Biol. Trace Elem. Res. 106, 1–28 (2005).
Symanski, E. & Hertz-Picciotto, I. Blood lead levels in relation to menopause, smoking and pregnancy history. Am. J. Epidemiol. 141, 1047–1058 (1995).
Gulson, B. L., Jameson, C. W., Mahaffey, K. R., Mizon, K. J., Korsch, M. J. & Vimpani, G. Pregnancy increases mobilization of lead from maternal skeleton. J. Lab. Clin. Med. 130, 51–62 (1997).
Sanders, A. P. et al. Towards prenatal biomonitoring in North Carolina: Assessing arsenic, cadmium, mercury and lead levels in pregnant women. PLoS ONE 7, e31354 (2012).
Eklund, G. & Oskarsson, A. Exposure of cadmium from infant formulas and weaning foods. Food Addit. Contam. 16, 509–519 (1999).
Cranton, E. M., Bland, J. S., Chatt, A., Krakovitz, R. & Wright, J. V. Standardization and interpretation of human hair for elemental concentrations. J. Holist. Med. 4, 10–20 (1982).
The authors appreciate the autistic subjects and their relatives for collaboration to this study. The authors thank K.Y. and M.S. for their technical contributions to hair trace element analysis.
The authors declare no competing financial interests.
About this article
Cite this article
Yasuda, H., Yasuda, Y. & Tsutsui, T. Estimation of autistic children by metallomics analysis. Sci Rep 3, 1199 (2013). https://doi.org/10.1038/srep01199
Biological Trace Element Research (2022)
Journal of Neurodevelopmental Disorders (2021)
BMC Public Health (2020)
Molecular Neurobiology (2020)